Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Wirth, S. et al. Sofosbuvir and ribavirin in adolescents 12 to 17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology
http://dx.doi.org/10.1002/hep.29278
(2017).
2. US Food & Drug Administration. Highlights of prescribing information for SOVALDI® (sofosbuvir) tablets, for oral use. US FDA
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204671s006lbl.pdf
(updated Mar 2017).
3. Wirth, S. Current treatment options and response rates in children with chronic hepatitis C. World J. Gastroenterol. 18, 99–104 (2012).
4. Jacobson, K. R., Murray, K., Zellos, A. & Schwarz, K. B. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J. Pediatr. Gastroenterol. Nutr. 34, 52–58 (2002).
5. Pawlotsky, J. M., Feld, J. J., Zeuzem, S. & Hoofnagle, J. H. From non-A, non-B hepatitis to hepatitis C virus cure. J. Hepatol. 62 (Suppl. 1), S87–S99 (2015).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献